Literature DB >> 9008289

Vitamin A levels and human immunodeficiency virus load in injection drug users.

R D Semba1, H Farzadegan, D Vlahov.   

Abstract

Although low plasma vitamin A levels are associated with increased mortality and higher vertical transmission during human immunodeficiency virus (HIV) infection, it is unknown whether plasma low vitamin A levels are a marker for circulating HIV load. We conducted a cross-sectional study within a prospective cohort study of injection drug users in order to evaluate the relationship between plasma vitamin A levels and HIV viral load. Plasma vitamin A level was measured by high-performance liquid chromatography. Infectious viral load was measured by quantitative microculture of serial fivefold dilutions of 10(6) peripheral blood mononuclear cells. A total of 284 HIV-infected adults (79 women, 205 men) were studied. Plasma vitamin A levels consistent with deficiency were found in 28.9% of adults. A total of 38.0% of women and 25.3% of men had vitamin A deficiency (P < 0.04). The median infectious viral load for the entire study population was 8 infectious units per million cells. No significant relationship between plasma vitamin A levels and infectious viral load was observed in these injection drug users. This study suggests that there is no correlation between HIV viral load and plasma vitamin A levels in injection drug users, and these variables may represent independent risk factors during HIV infection. HIV-infected adult women appear to be at higher risk of developing vitamin A deficiency.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9008289      PMCID: PMC170483          DOI: 10.1128/cdli.4.1.93-95.1997

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  22 in total

1.  Dilution assay statistics.

Authors:  L E Myers; L J McQuay; F B Hollinger
Journal:  J Clin Microbiol       Date:  1994-03       Impact factor: 5.948

2.  Vitamin A deficiency in non-vitamin-supplemented patients with AIDS: a cross-sectional study.

Authors:  D L Karter; A J Karter; R Yarrish; C Patterson; P H Kass; J Nord; J W Kislak
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1995-02-01

3.  Micronutrient concentrations in the HIV wasting syndrome.

Authors:  G O Coodley; M K Coodley; H D Nelson; M O Loveless
Journal:  AIDS       Date:  1993-12       Impact factor: 4.177

4.  Retinoic acid inhibition of ex vivo human immunodeficiency virus-associated apoptosis of peripheral blood cells.

Authors:  Y Yang; J Bailey; M S Vacchio; R Yarchoan; J D Ashwell
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

5.  Infant mortality and maternal vitamin A deficiency during human immunodeficiency virus infection.

Authors:  R D Semba; P G Miotti; J D Chiphangwi; G Liomba; L P Yang; A J Saah; G A Dallabetta; D R Hoover
Journal:  Clin Infect Dis       Date:  1995-10       Impact factor: 9.079

6.  Retinoic acid inhibits both the basal activity and phorbol ester-mediated activation of the HIV long terminal repeat promoter.

Authors:  G Towers; J Harris; G Lang; M K Collins; D S Latchman
Journal:  AIDS       Date:  1995-02       Impact factor: 4.177

7.  Maternal vitamin A deficiency and mother-to-child transmission of HIV-1.

Authors:  R D Semba; P G Miotti; J D Chiphangwi; A J Saah; J K Canner; G A Dallabetta; D R Hoover
Journal:  Lancet       Date:  1994-06-25       Impact factor: 79.321

8.  Specific nutrient abnormalities in asymptomatic HIV-1 infection.

Authors:  R S Beach; E Mantero-Atienza; G Shor-Posner; J J Javier; J Szapocznik; R Morgan; H E Sauberlich; P E Cornwell; C Eisdorfer; M K Baum
Journal:  AIDS       Date:  1992-07       Impact factor: 4.177

9.  Convergence of multiple nuclear receptor signaling pathways onto the long terminal repeat of human immunodeficiency virus-1.

Authors:  J A Ladias
Journal:  J Biol Chem       Date:  1994-02-25       Impact factor: 5.157

10.  Supplementation with vitamin A and iron for nutritional anaemia in pregnant women in West Java, Indonesia.

Authors:  D Suharno; C E West; D Karyadi; J G Hautvast
Journal:  Lancet       Date:  1993-11-27       Impact factor: 79.321

View more
  1 in total

1.  Retinoic acid promotes mouse splenic B cell surface IgG expression and maturation stimulated by CD40 and IL-4.

Authors:  Qiuyan Chen; A Catharine Ross
Journal:  Cell Immunol       Date:  2007-12-20       Impact factor: 4.868

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.